{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:15:48Z","timestamp":1765545348840},"reference-count":33,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T00:00:00Z","timestamp":1132099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To determine the association of central obesity with the components of the metabolic syndrome (i.e., hyperinsulinemia, hypertension, hypertriglyceridemia, low levels of high\u2010density lipoprotein cholesterol [HDL\u2010C]) and plasma levels of plasminogen activator inhibitor\u20101 (PAI\u20101) in young adults. We hypothesized that central obesity as determined by waist circumference would be predictive of components of the metabolic syndrome and of PAI\u20101.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data sources<\/jats:title><jats:p>Participants in this descriptive study consisted of 85 healthy young adults aged 19\u201322 years, 62% women who fasted for 12 h prior to data collection in the General Clinical Research Center at a major university hospital medical center in the southeastern United States.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The majority of the participants had one or more components of the metabolic syndrome (<jats:italic>n<\/jats:italic>= 43, 51%). Central obesity was present in 14.1% and was more common in women than men (\u03c7<jats:sup>2<\/jats:sup>= 5.11; <jats:italic>p<\/jats:italic>= 0.021). Central obesity was significantly and positively correlated with elevated blood pressure (BP) and levels of insulin and PAI\u20101 while being negatively correlated with HDL\u2010C. In multiple regression analyses, diastolic BP, insulin, and HDL\u2010C were predictors of waist circumference (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>= 0.615). In a separate multiple regression, PAI\u20101 was predicted by waist circumference (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>= 0.331).<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications for practice<\/jats:title><jats:p>Many otherwise healthy young adults have one or more components of the metabolic syndrome. Assessment and institution of preventative measures for obesity and the components of the metabolic syndrome should begin in childhood. Furthermore, determination of waist circumference especially in young women may aid the practitioner to identify those at risk for the metabolic syndrome earlier in their disease trajectory. Furthermore, insulin resistance is believed to occur initially in the trajectory of the metabolic syndrome, making it a principal contender for suitable interventions to reduce risk for both type 2 diabetes and cardiovascular disease (CVD). Homeostatic model assessment for insulin resistance was used to assess for insulin resistance among the euglycemic participants. Recording the presence of insulin resistance will aid the practitioner in determining if a low\u2010risk patient is in peril for development of type 2 diabetes and\/or CVD. Early cardiovascular risk recognition is vital to clinical practice as it allows more time for the practitioner to counsel patients for the essential planning needed to make lifestyle changes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1745-7599.2005.00083.x","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T22:19:58Z","timestamp":1132179598000},"page":"535-541","source":"Crossref","is-referenced-by-count":27,"title":["Central Obesity, the Metabolic Syndrome, and Plasminogen Activator Inhibitor\u20101 in Young Adults"],"prefix":"10.1111","volume":"17","author":[{"given":"Susan J.","family":"Appel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne S.","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha L.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,16]]},"reference":[{"issue":"3","key":"e_1_2_5_2_1","first-page":"236","article-title":"American College of Endocrinology position statement on the insulin resistance syndrome","volume":"9","author":"American College of Endocrinology (ACE)","year":"2003","journal-title":"Endocrine Practice"},{"issue":"1","key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/diacare.27.2007.S11","article-title":"Screening for type 2 diabetes","volume":"27","author":"American Diabetes Association (ADA)","year":"2004","journal-title":"Diabetes Care"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978677"},{"issue":"5","key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/diab.46.5.860","article-title":"Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease","volume":"46","author":"Alessi M. C.","year":"1997","journal-title":"Diabetes"},{"issue":"1","key":"e_1_2_5_6_1","first-page":"vii","article-title":"Metabolic syndrome: Broadening the understanding of African\u2010American woman's risk for cardiovascular disease","volume":"15","author":"Appel S. J","year":"2004","journal-title":"Journal of the National Black Nurses Association"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7599.2005.0052.x"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006199-200509000-00008"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7599.2004.tb00456.x"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(97)85585-0"},{"key":"e_1_2_5_11_1","unstructured":"Country Technology. (1999).Gulick II instruction manual. Retrieved May 25 2004 fromhttp:\/\/www.fitnessmart.com\/fitshopr\/67020.htm"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90373-K"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.356"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802422"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.12.2184"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00784-0"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.7.1177"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.10.1529"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00279.x"},{"issue":"1","key":"e_1_2_5_20_1","first-page":"78","article-title":"Hypofibrinolysis and increased PAI\u20101 are linked to atherothrombosis via insulin resistance and obesity","volume":"32","author":"Juhan\u2010Vague I.","year":"2000","journal-title":"Annals of Medicine"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.9.2057"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.2.179"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.4.978"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01288.x"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009696"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1301\/nr.2003.dec.397-412"},{"key":"e_1_2_5_28_1","volume-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults","author":"National Heart, Lung, and Blood Institute","year":"1998"},{"issue":"19","key":"e_1_2_5_29_1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"NCEP","year":"2001","journal-title":"JAMA"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.172"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/rp.59.1.207"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.4.1011"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802192"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1487"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1745-7599.2005.00083.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2005.00083.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:12:44Z","timestamp":1696975964000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2005.00083.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,16]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1745-7599.2005.00083.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2005.00083.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,16]]}}}